VERU INC. Dividends, Common Stock
VERU INC. (VERU) reported Dividends, Common Stock of $6.06 million for the 12-month period ending 2014-09-30, per its 10-K filed 2016-12-12.
Discontinued › Shareholders' Equity › Dividends
us-gaap:DividendsCommonStock · last filed 2016-12-12
- VERU INC. dividends, common stock for the quarter ending 2013-03-31 was $287.74K, a 6.66% increase year-over-year.
- VERU INC. dividends, common stock for the quarter ending 2012-12-31 was $1.71M, a 21.65% increase year-over-year.
- VERU INC. dividends, common stock for the quarter ending 2012-09-30 was $6.18M.
- VERU INC. dividends, common stock for the quarter ending 2012-06-30 was -$1.66M, a 11550.59% decline year-over-year.
- VERU INC. dividends, common stock for fiscal 2014 was $6.06M, a 18.80% decline from fiscal 2013.
- VERU INC. dividends, common stock for fiscal 2013 was $7.46M, a 20.44% increase from fiscal 2012.
- VERU INC. dividends, common stock for fiscal 2012 was $6.20M.
- VERU INC. dividends, common stock for fiscal 2011 was -$5.55M.
| Period end | Dividends, Common Stock 3 month | Dividends, Common Stock 6 month | Dividends, Common Stock 9 month | Dividends, Common Stock 12 month | Dividends, Common Stock 12 month as first filed |
|---|---|---|---|---|---|
| 2014-09-30 | $6.06M 10-K · filed 2016-12-12 | ||||
| 2013-09-30 | $7.46M 10-K · filed 2015-12-02 | -$7.46M 10-K · filed 2013-12-03 | |||
| 2013-03-31 | $287.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | $2.00M 10-Q · filed 2013-05-02 | $8.18M derived: sum of 3 quarters · filed 2014-12-02 | $6.52M derived: sum of 4 quarters · filed 2014-12-02 | |
| 2012-12-31 | $1.71M 10-Q · filed 2013-01-30 | $7.89M derived: sum of 2 quarters · filed 2014-12-02 | $6.23M derived: sum of 3 quarters · filed 2014-12-02 | $6.50M derived: sum of 4 quarters · filed 2014-12-02 | |
| 2012-09-30 | $6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02 | $4.52M derived: sum of 2 quarters · filed 2014-12-02 | $4.79M derived: sum of 3 quarters · filed 2014-12-02 | $6.20M 10-K · filed 2014-12-02 | -$6.20M 10-K · filed 2012-12-04 |
| 2012-06-30 | -$1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-31 | -$1.39M derived: sum of 2 quarters · filed 2013-05-02 | $14.42K 10-Q · filed 2012-07-31 | -$5.55M derived: sum of 4 quarters · filed 2013-12-03 | |
| 2012-03-31 | $269.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | $1.67M 10-Q · filed 2013-05-02 | -$3.89M derived: sum of 3 quarters · filed 2013-12-03 | -$3.88M derived: sum of 4 quarters · filed 2013-12-03 | |
| 2011-12-31 | $1.40M 10-Q · filed 2013-01-30 | -$4.16M derived: sum of 2 quarters · filed 2013-12-03 | -$4.15M derived: sum of 3 quarters · filed 2013-12-03 | -$4.15M derived: sum of 4 quarters · filed 2013-12-03 | |
| 2011-09-30 | -$5.57M derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | -$5.55M derived: sum of 2 quarters · filed 2013-12-03 | -$5.55M derived: sum of 3 quarters · filed 2013-12-03 | -$5.55M 10-K · filed 2013-12-03 | |
| 2011-06-30 | $14.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-31 | $14.50K derived: sum of 2 quarters · filed 2012-07-31 | $16.00K 10-Q · filed 2012-07-31 | -$4.13M derived: sum of 4 quarters · filed 2012-12-04 | |
| 2011-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-01 | $1.50K 10-Q · filed 2012-05-01 | -$4.15M derived: sum of 3 quarters · filed 2012-12-04 | ||
| 2010-12-31 | $1.50K 10-Q · filed 2012-01-31 | -$4.15M derived: sum of 2 quarters · filed 2012-12-04 | |||
| 2010-09-30 | -$4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | -$4.14M 10-K · filed 2012-12-04 | |||
| 2010-06-30 | $9.20K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |